113 related articles for article (PubMed ID: 1992023)
1. Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patients.
Vuillez JP; Peltier P; Mayer JC; Dubois F; Chetanneau A; Fumoleau P; Bertrand A; Chatal JF
J Nucl Med; 1991 Feb; 32(2):221-7. PubMed ID: 1992023
[TBL] [Abstract][Full Text] [Related]
2. Immunoscintigraphy of recurrences of gynecologic carcinomas.
Chatal JF; Fumoleau P; Saccavini JC; Thedrez P; Curtet C; Bianco-Arco A; Chetanneau A; Peltier P; Kremer M; Guillard Y
J Nucl Med; 1987 Dec; 28(12):1807-19. PubMed ID: 3500284
[TBL] [Abstract][Full Text] [Related]
3. Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibody.
Massuger LF; Kenemans P; Claessens RA; Verheijen RH; Schijf CP; Strijk SP; Poels LG; van Hoesel RG; Corstens FH
J Nucl Med; 1990 Nov; 31(11):1802-10. PubMed ID: 2230993
[TBL] [Abstract][Full Text] [Related]
4. Clinical immunoscintigraphy of ovarian carcinoma using iodine-131-labeled 145-9 monoclonal antibody.
Chung JK; Kang SB; Lee HP; Lee MC; Koh CS; Sakahara H; Endo K
J Nucl Med; 1993 Oct; 34(10):1651-5. PubMed ID: 8410277
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the diagnostic usefulness of CA125 immunoscintigraphy for ovarian carcinoma follow-up after treatment: contribution of this technique in Grenoble University Medical Center].
Vuillez JP; Levrot E; Mousseau M; Buffaz PD; Bolla M; Payan R; Comet M; Schaerer R
Bull Cancer; 1997 Nov; 84(11):1033-42. PubMed ID: 9536985
[TBL] [Abstract][Full Text] [Related]
6. [Basic study for immunoscintigraphy of ovarian cancer using 99mTc labeled F(ab')2 fragments of monoclonal antibody].
Sugiyama S
Kaku Igaku; 1994 Apr; 31(4):327-36. PubMed ID: 8196229
[TBL] [Abstract][Full Text] [Related]
7. False changes in CA 125 levels in ovarian cancer patients after infusion of OC125 fragments for diagnostic and therapeutic purpose.
Reinsberg J; Wagner U; Krebs D
Arch Gynecol Obstet; 1994; 255(1):9-18. PubMed ID: 8042882
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, Saclay.
Peltier P; Dutin JP; Chatal JF; Fumoleau P; Bourguet P; Liehn JC; Vuillez JP; Hérry JY; Loboguerrero A
Ann Oncol; 1993 Apr; 4(4):307-11. PubMed ID: 8518221
[TBL] [Abstract][Full Text] [Related]
9. The implications of patient antibody response for the clinical usefulness of immunoscintigraphy.
Perkins AC; Pimm MV; Powell MC
Nucl Med Commun; 1988 Apr; 9(4):273-82. PubMed ID: 3399224
[TBL] [Abstract][Full Text] [Related]
10. OC125 immunoscintigraphy in ovarian carcinoma: a comparison with alternative methods of assessment.
Maughan TS; Haylock B; Hayward M; Facey P; Evans WD; Shelley MD; Fish RG; Adams M
Clin Oncol (R Coll Radiol); 1990 Jul; 2(4):199-205. PubMed ID: 2261415
[TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy with indium-111 labeled monoclonal antibodies: the importance of a good display method.
Liehn JC; Hannequin P; Nasca S; Lebrun D; Fernandez-Valoni A; Valeyre J
Clin Nucl Med; 1989 Mar; 14(3):187-91. PubMed ID: 2736845
[TBL] [Abstract][Full Text] [Related]
12. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
Chetanneau A; Baum RP; Lehur PA; Liehn JC; Perkins AC; Bares R; Bourguet P; Herry JY; Saccavini JC; Chatal JF
Eur J Nucl Med; 1990; 17(5):223-9. PubMed ID: 2083556
[TBL] [Abstract][Full Text] [Related]
13. [The diagnostic value of immunoscintigraphy using the monoclonal antibody OV-TL3 in patients with ovarian carcinoma].
Buist MR; Roos JC; Vermorken JB; Golding RP; Burger CW; Kenemans P
Ned Tijdschr Geneeskd; 1991 Jan; 135(4):126-30. PubMed ID: 2002855
[TBL] [Abstract][Full Text] [Related]
14. Clinical immunoscintigraphy of recurrent ovarian cancer with indium 111-labeled B72.3 monoclonal antibody.
Krag DN; Ford P; Smith L; Taylor M; Schneider PD; Bushberg JT; Goodnight JE
Arch Surg; 1993 Jul; 128(7):819-23. PubMed ID: 8317965
[TBL] [Abstract][Full Text] [Related]
15. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies].
Peking A; Marinov V
Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments.
Barzen G; Mayr AC; Langer M; Becker R; Cordes M; Zwicker C; Koppenhagen K; Felix R
Eur J Nucl Med; 1989; 15(1):42-8. PubMed ID: 2917583
[TBL] [Abstract][Full Text] [Related]
17. [Immunoscintigraphy of oncologic tumors].
Barzen G
Radiol Diagn (Berl); 1990; 31(3):209-20. PubMed ID: 2367627
[TBL] [Abstract][Full Text] [Related]
18. Use of indium-111-labeled OC-125 monoclonal antibody in the detection of ovarian cancer.
Hunter RE; Doherty P; Griffin TW; Gionet M; Hnatowich DJ; Bianco JA; Dillon MB
Gynecol Oncol; 1987 Jul; 27(3):325-39. PubMed ID: 3497845
[TBL] [Abstract][Full Text] [Related]
19. [REGAJ diagnosis of recurrence of ovarian cancer].
Paterok EM; Jäger W; Feistel H; Lang N; Wolf F
Gynakol Rundsch; 1989; 29 Suppl 2():360-3. PubMed ID: 2613050
[No Abstract] [Full Text] [Related]
20. Monitoring cancer antigen 125 in serum of ovarian cancer patients after administration of 131I-labeled F(ab')2 fragments of OC125 antibody.
Reinsberg J; Schultes B; Wagner U; Krebs D
Clin Chem; 1993 May; 39(5):891-6. PubMed ID: 8485883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
